人工血管市场:各市场区隔规模，占有率，法律规章，偿付，手术，2033年为止的预测

血管移植物是由天然组织或合成材料製成的管子，经由手术植入静脉或动脉。用于外科手术过程中修復、绕过或替换部分血管的植入物。它也用于修復受损或患病的动脉区域，或替换大动脉（例如主动脉）的整个部分。人工血管依材料分为自体血管、同种异体血管及合成血管移植物。自体血管移植物是取自个体并用于同一个体的人造血管。同种异体移植物是取自另一个人并用于治疗患者的移植物。合成血管移植物是使用聚合物製成的人造血管。聚酯和聚四氟乙烯（PTFE）是两种用于製造合成血管移植物的合成材料。合成（聚对苯二甲酸乙二醇酯）血管移植物由聚合物线编织的管製成，而合成 PTFE 血管移植物则由机械拉伸聚四氟乙烯片製成。

人造血管用于修復主动脉并治疗需要绕行週边血管的疾病。这些疾病包括发生在胸主动脉（胸主动脉瘤- TAA）和腹主动脉（腹主动脉瘤- AAA）的主动脉瘤、主动脉剥离、週边动脉疾病（PAD）和支持血液透析的脉管系统。

本报告提供全球人工血管市场相关资料详细考察，提供市场上竞争情形，SWOT分析，到2033年为止的市场预测，地区，各国的趋势等资讯。

目录

已上市的人工血管和不断变化的竞争格局

• 主要的产业趋势洞察
• 人工血管的各市场区隔整体市场收益和2015年～2033年的市场展望
• 各市场区隔的手术总数，台数，平均销售价格，市场价值相关详细资料

世界，地区，各国洞察

• 人工血管市场SWOT分析
• 人工血管市场相关竞争动态的洞察和趋势
• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规状况

Vascular Grafts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. Vascular Grafts are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta. Vascular grafts are classified into autografts, allografts and synthetic vascular grafts on the basis of the materials. Autograft vascular grafts are vascular grafts taken from the individual and used in the same individual. These grafts are not tracked in this market. Allograft vascular grafts are vascular grafts taken from another individual and used in the treated patient. Synthetic vascular grafts are the grafts which are manufactured using polymers. Polyester and Polytetrafluoroethylene (PTFE) are the two synthetic materials used to construct synthetic vascular grafts. Synthetic (polyethylene terephthalate) vascular grafts are made from polymer yarn woven tubes whereas Synthetic PTFE vascular grafts are made by mechanically stretching sheets of polytetrafluoroethylene.

Vascular grafts are used to treat conditions which require aortic repair or peripheral vessel bypass. These conditions include aortic aneurysms that occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA), aortic dissections, peripheral artery disease (PAD) and end-stage renal disease cases that have insufficient vasculature to support hemodialysis.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Vascular Grafts market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Vascular Grafts market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Vascular Grafts market.
• Competitive dynamics insights and trends provided Vascular Grafts market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: W. L. Gore & Associates Inc, Terumo Corp, Getinge AB, Artivion Inc, CR Bard Inc, B. Braun Melsungen AG, LeMaitre Vascular Inc, Japan Lifeline Co Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Vascular Grafts marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Vascular Grafts market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Vascular Grafts market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Vascular Grafts market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.